- Home
- COLL vs ML Comparison
COLL vs ML Comparison
Compare COLL & ML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- ML
- Stock Information
- Founded
- COLL 2002
- ML 2013
- Country
- COLL United States
- ML United States
- Employees
- COLL N/A
- ML N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- ML Retail: Computer Software & Peripheral Equipment
- Sector
- COLL Health Care
- ML Technology
- Exchange
- COLL Nasdaq
- ML Nasdaq
- Market Cap
- COLL 910.2M
- ML 969.9M
- IPO Year
- COLL 2015
- ML N/A
- Fundamental
- Price
- COLL $28.07
- ML $85.55
- Analyst Decision
- COLL Strong Buy
- ML Buy
- Analyst Count
- COLL 5
- ML 6
- Target Price
- COLL $43.60
- ML $94.25
- AVG Volume (30 Days)
- COLL 438.9K
- ML 122.9K
- Earning Date
- COLL 05-08-2025
- ML 05-06-2025
- Dividend Yield
- COLL N/A
- ML N/A
- EPS Growth
- COLL 43.56
- ML N/A
- EPS
- COLL 1.86
- ML 0.76
- Revenue
- COLL $631,449,000.00
- ML $545,905,000.00
- Revenue This Year
- COLL $20.00
- ML $25.54
- Revenue Next Year
- COLL $3.93
- ML $25.16
- P/E Ratio
- COLL $15.63
- ML $113.82
- Revenue Growth
- COLL 11.41
- ML 28.92
- 52 Week Low
- COLL $27.28
- ML $36.65
- 52 Week High
- COLL $42.29
- ML $106.82
- Technical
- Relative Strength Index (RSI)
- COLL 37.90
- ML 42.25
- Support Level
- COLL $29.01
- ML $85.82
- Resistance Level
- COLL $30.53
- ML $86.98
- Average True Range (ATR)
- COLL 0.82
- ML 0.82
- MACD
- COLL -0.10
- ML -0.17
- Stochastic Oscillator
- COLL 5.73
- ML 18.77
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About ML MoneyLion Inc.
MoneyLion Inc is a mobile banking and financial membership platform that empowers people to take control of their finances. It is a full-service digital platform to deliver mobile banking, lending, and investment solutions. The company offers a personalized, all-in-one, digital financial platform that provides convenient, low-cost access to banking, borrowing, and investing solutions tailored for its customers, rooted in data, and delivered through its proprietary technology platform.